HolderBook

EVOKE PHARMA INC (EVOK)

Institutional ownership reported to the SEC as of Q3 2025, across 28 quarters.

15
Reporting holders
$2.9M
Reported value
0.0%
Held as options
+5
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
MORGAN STANLEY$792.0K159,3580.00%5q+248896.9%+$791.7K
Nantahala Capital Management, LLC$736.3K148,1530.03%5qHELD
Bleichroeder LP$727.6K146,3950.14%5q+112.9%+$385.9K
National Wealth Management Group, LLC$398.2K80,1300.15%newNEW
DRW Securities, LLC$118.0K23,7420.00%newNEW
VANGUARD GROUP INC$93.2K18,7590.00%newNEW
TWO SIGMA SECURITIES, LLC$51.9K10,4370.01%newNEW
OSAIC HOLDINGS, INC.$16.4K3,0100.00%newNEW
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$1.4K2720.00%newNEW
ROYAL BANK OF CANADA$1.0K1900.00%newNEW
BlackRock, Inc.$6061220.00%5qHELD
SBI Securities Co., Ltd.$378760.00%4q+1.3%
Tower Research Capital LLC (TRC)$199400.00%3q-98.0%-$9.7K
NewEdge Advisors, LLC$84170.00%5qHELD
BANK OF AMERICA CORP /DE/$60120.00%5q+20.0%

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q3 202515$2.9M590,7137410.0%
Q2 202510$603.6K232,0221210.0%
Q1 202510$678.2K262,2063100.0%
Q4 20248$965.6K218,4560210.0%
Q3 202412$994.6K208,31911000.0%
Q2 202415$2.0M3,826,8904320.0%
Q1 202414$1.9M3,164,1376320.0%
Q4 20239$72.2K68,7351310.0%
Q3 20239$92.4K67,1570400.0%
Q2 20239$97.4K59,1660210.0%
Q1 20239$102.1K53,7511010.0%
Q4 20228$104.2K38,8934010.0%
Q3 20227$129.0K62,4200059.3%
Q2 20228$284.0K70,180100019.7%
Q1 202218$988.0K1,997,5122550.1%
Q4 202122$1.2M2,047,9174443.7%
Q3 202123$5.8M4,204,3434445.7%
Q2 202121$6.9M4,504,48135311.0%
Q1 202127$9.5M4,280,13755417.8%
Q4 202032$8.2M2,690,74689515.1%
Q3 202026$10.9M1,862,922143420.0%
Q2 202018$5.0M1,400,5445510.0%
Q1 202016$1.7M1,462,1052220.0%
Q4 201916$2.7M1,656,3663310.0%
Q3 201917$1.3M1,484,0565320.0%
Q2 201917$842.0K1,347,5284230.0%
Q1 201922$2.7M1,814,7046250.0%
Q4 201819$8.0M3,212,9830000.0%